<p><span style="font-size: 24px;"><b style=""><span style="background-color: rgb(255, 255, 0);"><font color="#ce0000">BPM Protocol in Ahmadi hospital<br><br></font></span></b></span><font color="#ffffff" style="background-color: rgb(255, 0, 0);"><b>Handling Blood Product<br>Storage of Blood Product <br>Transfusion Indication <br>Product Selection <br>Dosage <br>Infusion Rate <br>Special Request for special cases</b><br><br></font><span style="font-size: 18px;"><font color="#ffffff" style=""><span style="background-color: rgb(255, 0, 0); font-size: 24px;">Handling Blood Product BP</span><span style="background-color: rgb(255, 255, 255);"><span style="font-size: 24px;">&nbsp;</span><br></span></font></span><span style="text-align: var(--bs-body-text-align);"><font color="#000000" style=""><b>1. Consent of patient
    <br>2. Obtaining blood from blood bank
    <br>3. Correct identification of patient
    <br>4. Administration of blood and blood component
    <br>5. Patient monitoring<br>6. Duration of transfusion of blood product
    <br>7. Identification of transfusion reaction</b></font></span><span style="font-size: 18px; text-align: var(--bs-body-text-align);"><font color="#000000" style=""><b>&nbsp;<br></b></font><br></span><span style="font-size: 24px; background-color: rgb(255, 0, 0);"><font color="#ffffff" style="">Storage of Blood Product</font></span><b><br><font color="#000000">1. Blood bank is the only place where blood is stored</font></b><font color="#ff0000"> (not in ward or domestic
    fridge)</font>.<b><br><font color="#000000">&nbsp;2. Blood should be collected from blood bank only when it is required, and patient
    is ready for transfusion.<br>&nbsp;3. Unused blood and blood component should be returned to blood bank within 30
    minutes.</font> </b><font color="#ff0000">(30 minutes rule)
    <br></font><font color="#000000"><b>4. Platelets is not stored in Blood bank Ahmadi Hospital; it is ordered from Kuwaiti
    Central Blood bank for definite patient.
    <br>5. Pediatric blood is less than 5 days; therefore, it is not stored in Blood bank fridge,
    ordered from KCBB corresponding to both&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;baby &amp; mother blood type &amp; volume
    requested for transfusion<br><br></b></font></p><span style="font-size: 24px; background-color: rgb(255, 0, 0);"><font color="#ffffff">Transfusion Indication<br></font></span><b><font color="#ce0000"><span style="font-size: 18px;">Component<br></span></font></b><font style="background-color: rgb(255, 255, 255);"><b style=""><font color="#000000">&nbsp; &nbsp;PRBC
    </font><br><font color="#000000"> Platelets concentration
    </font><br><font color="#000000"> Fresh frozen Plasma&nbsp;</font><br><font color="#000000">&nbsp; &nbsp;Cryoprecipitate&nbsp;</font><br><font color="#ce0000"><br></font></b></font><b><span style="font-size: 18px;"><font color="#ce0000">Indication for PRBCs</font></span><br></b><font color="#000000">&nbsp; Clinical signs and symptoms of severe anemia.
    <br>&nbsp; Evidence of acute loss of 15% of total blood volume (&gt;750 ml).<br>&nbsp; &nbsp; &nbsp;Hemoglobin of 7 g/dl or less.&nbsp;<br>&nbsp; &nbsp; Hemoglobin of 8 g/dl or less for patients undergoing orthopedic or cardiac surgery.<br>&nbsp; &nbsp; Other indication such as thalassemia major patient)&nbsp;<br></font><b><font color="#ce0000"><span style="font-size: 18px;">Indication for Platelets concentration&nbsp;&nbsp;</span><br></font></b><font color="#000000"><b>&nbsp; &nbsp; Actively bleeding patient:
    <br></b>&nbsp; &nbsp; &nbsp; &nbsp;To keep platelet counts above 50x109 /L &amp; above 100x109 if there is disseminated
    intravascular coagulation.<br>&nbsp; &nbsp; &nbsp; &nbsp;For bleeding due to platelet dysfunction.
    <br>&nbsp; &nbsp; &nbsp; &nbsp;Patients having cardiopulmonary by-pass (CPM) who exhibit perioperative bleeding
    and /or platelet dysfunction.<br><b>&nbsp; Preparation of invasive procedure&nbsp;<br></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Elective central venous catheter placement with platelet count &lt;20x109 /L.
    <br>&nbsp; &nbsp; &nbsp; &nbsp; Elective diagnostic lumbar puncture with platelet count &lt;50x109/L.
    <br>&nbsp; &nbsp; &nbsp; &nbsp; Neuro or ocular surgery with platelet count &lt;100x109/L.
    <br>&nbsp; &nbsp; &nbsp; &nbsp; Major surgery or delivery with platelet count &lt;50x109/L.
    <br>&nbsp; &nbsp; &nbsp; &nbsp; Neuroaxial anesthesia with platelet count &lt;80x189/L.&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Percutaneous liver biopsy with platelet count &lt;50x109/L&nbsp;</font><br><b><font color="#000000"><span style="font-size: 18px;">&nbsp; &nbsp; &nbsp;Prevention of bleeding
    </span><br></font></b><font color="#000000">&nbsp; &nbsp; &nbsp; &nbsp;Bone marrow suppression with platelet count &lt;10x109/L.&nbsp;<br></font><br><b><font color="#ce0000"><span style="font-size: 18px;">&nbsp; &nbsp;Indication for Fresh Frozen Plasma FFP</span><br></font></b><font color="#000000">&nbsp;&nbsp; &nbsp; &nbsp; &nbsp;Major bleeding or preparation for an urgent invasive procedure.<br>&nbsp;&nbsp; &nbsp; &nbsp; &nbsp;Treatment of multiple coagulation factor deficiencies.
    <br>&nbsp; &nbsp; &nbsp; &nbsp; Massive transfusion protocol.&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Plasma exchange for thrombotic thrombocytopenia purpura.</font><br><b><font color="#ce0000"><span style="font-size: 18px;">&nbsp; &nbsp;Indication for Cryoprecipitate&nbsp;</span><br></font></b><font color="#000000">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Plasma fibrinogen level below 100 mg/dl or dysfunctional fibrinogen.&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; FXIII deficiency.<br><br></font><b style=""><font color="#ffffff" style=""><span style="font-size: 24px; background-color: rgb(255, 0, 0);">Product selection<br></span><br></font></b><b><span style="font-size: 18px;">&nbsp; &nbsp; &nbsp;</span></b><font color="#000000"><b><span style="font-size: 18px;">Rhesus factor (RH) compatibility</span><br></b>&nbsp;&nbsp; &nbsp; &nbsp; &nbsp;Only applied to packed red blood cell (PRBC) and platelet concentration.
    <br>&nbsp; &nbsp; &nbsp; &nbsp; Rh positive patient can receive Rh + or Rh- component.&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Rh negative patient preferably receives Rh- component except in urgent cases if Rhcomponent not available and patient either male or&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;female above age of 50.<br><span style="font-size: 18px;">&nbsp;&nbsp; &nbsp; &nbsp;</span><b><span style="font-size: 18px;">PRBC</span></b><span style="font-size: 18px;">&nbsp;</span><br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Blood Group (ABO) compatibility is the first choice.
    <br>&nbsp; &nbsp; &nbsp; &nbsp;  If ABO compatibility is not available, it shifts to the second and third choice consecutively.&nbsp;<br><b><span style="font-size: 18px;">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Platelet Concentration&nbsp;</span><br></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;ABO compatibility is the first choice, but any ABO type component may be used.&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; In case of platelets refractoriness, group specific and Human Leukocyte Antigen (HLA)
    matched maybe indicated.
    <br>&nbsp; &nbsp; &nbsp; &nbsp; <b><span style="font-size: 18px;">Cryoprecipitate</span></b>
    <br>&nbsp; &nbsp; &nbsp; &nbsp;  ABO compatibility is the first choice, but any ABO type component may be used.&nbsp;<br><b><span style="font-size: 18px;">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;FFP&nbsp;</span></b><br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Blood Group (ABO) compatibility is the first choice.<br>&nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;If ABO compatibility is not available, it shifts to the second and third choice
    consecutively.&nbsp;</font><font color="#000000"><br></font><b><font style="background-color: rgb(255, 255, 255);" color="#ce0000"><span style="font-size: 18px;">Rh Compatibility&nbsp;</span><br></font></b>&nbsp;<font color="#000000"> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Rh (+ve) Positive Patient</font><font color="#000000"><br></font><font color="#000000">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Can receive either Rh+ <b><u>or</u></b> Rh- components<br></font><font color="#000000">&nbsp; &nbsp; &nbsp; &nbsp;  Rh (-ve) Negative Patient
    <br></font><font color="#000000">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;  Preferably receive Rh- components<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;  Rh(+ve) may be given for urgent cases if Rh(-ve) is not available and
    patient is either male or “female above age of 50”<br></font><b><font color="#ce0000"><span style="font-size: 18px;">PRBC compatibility table</span></font></b><br><p><span style="color: rgb(255, 255, 255); font-size: 18px; font-weight: var(--bs-body-font-weight); text-align: var(--bs-body-text-align);"></span></p><p><span style="font-size: 24px;"><b style=""><span style="background-color: rgb(255, 255, 0);"><font color="#ce0000"></font></span></b></span></p><table class="table table-bordered"><tbody><tr><th colspan="3"><font color="#000000" style="background-color: rgb(247, 198, 206);">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Red Blood cell Compatibility Chart&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</font></th></tr><tr><th colspan="2"><p><span style="background-color: rgb(255, 239, 198);">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Patient&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</span></p></th><th><span style="background-color: rgb(255, 239, 198);">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Donor&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</span></th></tr><tr><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;ABO Group</th><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;ABO antigen on RBC</th><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Blood Type</th></tr><tr><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; O</th><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;None</th><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; O</th></tr><tr><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; A</th><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;A</th><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;A and O</th></tr><tr><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;B</th><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; B</th><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; B And O</th></tr><tr><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;AB</th><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;A and B</th><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;AB , A, B and O</th></tr></tbody></table><b><span style="font-size: 18px;"><font color="#ce0000">FFP Fresh Frozen Plasma compatibility table&nbsp;<br><br><br></font></span></b><table class="table table-bordered"><tbody><tr><th colspan="3"><font color="#000000" style="background-color: rgb(247, 198, 206);">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Plasma Compatibility Chart&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</font></th></tr><tr><th colspan="2"><p><span style="background-color: rgb(255, 239, 198);">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Patient&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</span></p></th><th><span style="background-color: rgb(255, 239, 198);">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Donor&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</span></th></tr><tr><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;ABO Group</th><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;ABO antigen on RBC</th><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Blood Type</th></tr><tr><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; O</th><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;A and B</th><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;O,A,B and AB</th></tr><tr><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; A</th><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;A</th><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;A and O</th></tr><tr><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;B</th><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; B</th><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; B And O</th></tr><tr><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;AB</th><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;None</th><th>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; AB</th></tr></tbody></table><br><b><span style="font-size: 24px; background-color: rgb(255, 0, 0);"><font color="#ffffff">Dosage<br><br></font></span><span style="font-size: 18px;"><font color="#ce0000"><u>PRBCs</u></font></span></b>&nbsp;&nbsp;<font color="#000000"><br>&nbsp; &nbsp; <b>&nbsp;250 ml PRBC unit</b> raises (Hb) of an average size adult by 1 g/dl, HCT 3-4 %
    <br>&nbsp; &nbsp;  <b>Non-Bleeding cases</b><br>&nbsp; &nbsp; &nbsp; &nbsp;Transfused blood unit-by-unit basis according to patient symptoms
    In Chronic anemia &amp; Cardiac disease, rate of administration does not&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; exceed 20-
    40 drops/min<br>&nbsp; &nbsp;  <b>Actively bleeding cases
    </b><br>&nbsp; &nbsp; &nbsp; &nbsp;Supportive blood transfusion until control bleeding<br>&nbsp; &nbsp; &nbsp; &nbsp;Activate massive transfusions Protocol if:
    <br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 1. Actual or anticipated blood transfusion of 4 units PRBC in 4 hours<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 2. Hemodynamically unstable patient<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 3. Anticipated ongoing bleeding</font>&nbsp;<br><font color="#ce0000"><u><b><span style="font-size: 18px;">Platelet Concentration<br></span></b></u></font><font color="#000000">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<b><span style="font-size: 14px;">6-unit pooled platelet concentrate/ </span></b>1 unit apheresis platelet should increase the
    platelet count approximately 25-50 x109 /L<br>&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<b>&nbsp;Reassess the patient’s clinical condition</b> and check platelets count, after each
    transfusion<br>&nbsp; &nbsp; &nbsp; <b>Give </b>further doses if needed.&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; <b>Single dose of platelets for</b> Routine Transfusion&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; <b>More than single dose of platelets</b> Severe thrombocytopenia, bleeding in critical<br>&nbsp; &nbsp; &nbsp; &nbsp;site:
    <br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;1. Central Nervous System
    <br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;2. eyes&nbsp;<br><b>&nbsp; &nbsp; &nbsp; &nbsp;Insufficient platelets increment causes<br></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 1. Increase consumption (sever sepsis), DIC<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 2. Platelet destruction (sever sepsis, drug induced)
    <br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 3. Platelet refractoriness:
    <br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 4. Allo-immunization&nbsp;<br></font><u style=""><b style=""><span style="font-size: 18px;"><font color="#000000"><br></font></span></b></u><b><span style="font-size: 18px;"><font color="#ce0000" style=""><u>Fresh Frozen Plasma FFP</u><br></font></span></b><font color="#000000"><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Each FFP unit volume 200 ml, dose of 10-15 ml/Kg of Patient body weight&nbsp;&nbsp;<br></b></font><font color="#ce0000"><u><b><span style="font-size: 18px;">Cryoprecipitate</span></b></u></font><span style="font-size: 18px;">&nbsp;&nbsp;</span><br><font color="#000000"><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Dose of 1 unit / 10 Kg of patient body weight&nbsp;&nbsp;<br></b></font><u style=""><b style=""><span style="font-size: 18px;"><font color="#000000"><br></font></span></b></u><span style="font-size: 24px; background-color: rgb(255, 0, 0);"><b><font color="#ffffff">Infusion Rate</font></b></span>&nbsp;<br><u style=""><b style=""><span style="font-size: 18px;"><font color="#000000"><br></font></span></b></u><u><b><font color="#ce0000">PRBCs</font></b></u>&nbsp;<br><font color="#000000"><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 1. First 15 minutes<br></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;1-2 ml/min (60-120 ml/hour)
    <br><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 2. After 15 minutes
    <br></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; As rapidly as tolerated; approx. 4 ml/min (240 ml/hour)<br><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 3. Pediatric Dosage/rate
    <br></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 10 ml/Kg; not to exceed 15 ml/Kg at 2-5 ml/Kg/hour<br><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 4. Special Consideration<br></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;1-2 hours for hemodynamically stable recipient; infusion should not exceed 4 hrs.
    adjust flow rate to 1ml/Kg/hour for patient at risk&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;of fluid overload.&nbsp;<br></font><u style=""><b style=""><span style="font-size: 18px;"><font color="#000000"><br></font></span></b></u><b><span style="font-size: 14px;"><font color="#ce0000"><u>Platelet Concentration</u></font></span></b><br><span style="font-size: 14px;"><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</b><font color="#000000"><b>1. First 15 minutes<br></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;2-5 ml/min (120–300 ml/hour)
    <br><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 2. After 15 minutes<br></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;As rapidly as tolerated; approx. 300 ml/hour
    <br><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 3. Pediatric Dosage/rate<br></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 5-10 ml/Kg; not to exceed 15 ml/Kg at 2-5 ml/Kg/hour<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <b>4. special Consideration<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</b>Usually given over 1-2 hours
    For patients at risk of fluid overload, use slower flow rate&nbsp;<br><br></font></span><b style=""><u style=""><span style="font-size: 18px;"><font color="#ce0000">Fresh Frozen Plasma FFP</font></span></u><br></b><font color="#000000"><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;1. First 15 minutes
    <br></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;2-5 ml/min (120-300 ml/hour)
    <br><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;2. After 15 minutes<br></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; As rapidly as tolerated; approx. 300 ml/hour
    <br><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;3. Pediatric Dosage/rate
    <br></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<b>Acute hemorrhage:</b> 15-30 ml/Kg as indicated<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <b>Clotting deficiency: </b>10-15 ml/kg at 1-2 ml/min
    <br><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 4. Special Consideration<br></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Thaw time needed before issue.<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Expiration- 24 hours after thaw time<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Do Not hang longer than 24 hours<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; For patient at risk of fluid overload, use slower flow rate&nbsp;<br></font><u style=""><b style=""><span style="font-size: 18px;"><font color="#000000"><br></font></span></b></u><b style=""><font color="#ce0000"><span style="font-size: 18px;"><u>Cryoprecipitate</u></span>
    </font></b><br><font color="#000000"><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;1. First 15 minutes<br></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;As rapidly as tolerated
    </font><br><font color="#000000"><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;2. After 15 minutes<br></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;As rapidly as tolerated; approx. 5-10 ml/min
    </font><br><font color="#000000"><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;3. Pediatric Dosage/rate
    <br></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;1-2 U/10 Kg, not faster than 1 ml/Kg/min<br><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;4. Special Consideration<br></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Infuse ASAP after thawing; pooling is preferred<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Maximum benefit if used within 2 hours</font><b><font color="#ffffff" style=""><u style="background-color: rgb(255, 0, 0);"><span style="font-size: 18px;"><br><br></span></u><span style="font-size: 24px; background-color: rgb(255, 0, 0);">Special Request</span></font></b>&nbsp;<br><br><b><u><span style="font-size: 18px;"><font color="#ce0000">Irradiated Blood<br></font></span></u><font color="#000000">Used for PRBC and platelet Concentration to prevent (TA_GVHD)&nbsp;<br>Indication for:&nbsp;<br></font></b><font color="#000000"> First &amp; second-degree relative donors
    <br> Intrauterine transfusion
    <br> Neonatal transfusion/exchange transfusion&nbsp;<br>&nbsp; &nbsp;Patient on purine analogues, anti-thymocyte or alemtuzumab&nbsp;<br>&nbsp; &nbsp;Hematopoietic stem cell transplantation (HSCT)<br><br></font><b><font color="#ce0000"><u>Washed Blood</u></font></b>&nbsp;<br><b><font color="#000000">Used for PRBC and platelet Concentration to eliminate plasma from the blood product&nbsp;<br>Indication for:&nbsp;<br></font></b><font color="#000000">&nbsp; Severe or recurrent allergic reaction<br>&nbsp; History of anaphylaxis&nbsp;<br>&nbsp; &nbsp; Immunoglobulin A (IgA) deficiency
    <br> Patient at risk for hypokalemia
    <br> Transfusion of the washed unit should be completed within 24 hrs. for PRBC
    &amp; within 4 hrs. for platelet concentration&nbsp;<br></font><u style=""><b style=""><span style="font-size: 18px;"><font color="#000000"><br></font></span></b></u><b><span style="font-size: 18px;"><u><font color="#ce0000">Sickle Cell Negative RBC<br></font></u></span><font color="#000000">Indication for:&nbsp;<br></font></b><font color="#000000">&nbsp; Intrauterine transfusion<br>&nbsp; Neonate&nbsp;<br>&nbsp; &nbsp; Patient with sickle cell disease.<br><br></font><b><span style="font-size: 24px; background-color: rgb(255, 255, 0);"><font color="#00ffff">Finish this part then quiz for part 2</font></span></b><span style="font-size: 24px;">&nbsp;<br></span><span style="font-size: 24px; background-color: rgb(255, 255, 255);"><b style=""><font color="#00ffff" style="">Then certificate part 2 appears&nbsp;&nbsp;<br><br></font></b></span><b><span style="font-size: 24px;"><font color="#00ffff">Congratulation on finishing this program</font></span></b><span style="font-size: 24px;">&nbsp;</span><span style="font-size: 24px; background-color: rgb(255, 255, 255);"><b style=""><font color="#00ffff" style=""></font></b></span><span style="font-size: 24px;"></span><font color="#000000"></font><b><font color="#000000"></font></b><u style=""><b style=""><span style="font-size: 18px;"></span></b></u>